These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 36897808)
1. Ezh2 Knockout in B Cells Impairs Plasmablast Differentiation and Ameliorates Lupus-like Disease in MRL/lpr Mice. Zheng X; Dozmorov MG; Strohlein CE; Bastacky S; Sawalha AH Arthritis Rheumatol; 2023 Aug; 75(8):1395-1406. PubMed ID: 36897808 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice. Rohraff DM; He Y; Farkash EA; Schonfeld M; Tsou PS; Sawalha AH Arthritis Rheumatol; 2019 Oct; 71(10):1681-1690. PubMed ID: 31106974 [TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2. Yasuda K; Watkins AA; Kochar GS; Wilson GE; Laskow B; Richez C; Bonegio RG; Rifkin IR PLoS One; 2014; 9(7):e103478. PubMed ID: 25076492 [TBL] [Abstract][Full Text] [Related]
4. Ezh2 knockout in B cells impairs plasmablast differentiation and ameliorates lupus-like disease in MRL/lpr mice: comment on the article by Zheng et al. Huang AF; Xu WD Arthritis Rheumatol; 2023 Nov; 75(11):2064-2065. PubMed ID: 37134145 [No Abstract] [Full Text] [Related]
5. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4. White CA; Seth Hawkins J; Pone EJ; Yu ES; Al-Qahtani A; Mai T; Zan H; Casali P Autoimmunity; 2011 Dec; 44(8):585-98. PubMed ID: 21585311 [TBL] [Abstract][Full Text] [Related]
6. Methionine Commits Cells to Differentiate Into Plasmablasts Through Epigenetic Regulation of BTB and CNC Homolog 2 by the Methyltransferase EZH2. Zhang M; Iwata S; Hajime M; Ohkubo N; Todoroki Y; Miyata H; Ueno M; Hao H; Zhang T; Fan J; Nakayamada S; Yamagata K; Tanaka Y Arthritis Rheumatol; 2020 Jul; 72(7):1143-1153. PubMed ID: 31961063 [TBL] [Abstract][Full Text] [Related]
7. EZH2 inhibition dampens autoantibody production in lupus by restoring B cell immune tolerance. Yang Y; Li M; Zhu Y; Liu K; Liu M; Liu Y; Zhu G; Luo H; Zuo X; Zhang H; Guo M Int Immunopharmacol; 2023 Jun; 119():110155. PubMed ID: 37044035 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice. Zhang X; Wang G; Bi Y; Jiang Z; Wang X Int Immunopharmacol; 2022 Nov; 112():109133. PubMed ID: 36113317 [TBL] [Abstract][Full Text] [Related]
9. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501 [TBL] [Abstract][Full Text] [Related]
10. Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice. Ju ZL; Shi GY; Zuo JX; Zhang JW; Immunology; 2007 Feb; 120(2):281-9. PubMed ID: 17073941 [TBL] [Abstract][Full Text] [Related]
13. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus. Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816 [TBL] [Abstract][Full Text] [Related]
14. Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice. Bökers S; Urbat A; Daniel C; Amann K; Smith KG; Espéli M; Nitschke L J Immunol; 2014 Apr; 192(7):2994-3002. PubMed ID: 24600033 [TBL] [Abstract][Full Text] [Related]
15. TIGIT-Fc fusion protein alleviates murine lupus nephritis through the regulation of SPI-B-PAX5-XBP1 axis-mediated B-cell differentiation. Zhao J; Li L; Feng X; Gao C; Gao L; Zhan Y; Wang Z; Zhao M; Yin H; Lu Q J Autoimmun; 2023 Sep; 139():103087. PubMed ID: 37481835 [TBL] [Abstract][Full Text] [Related]
16. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development. Wang M; Chen H; Qiu J; Yang HX; Zhang CY; Fei YY; Zhao LD; Zhou JX; Wang L; Wu QJ; Zhou YZ; Zhang W; Zhang FC; Zhang X; Lipsky PE J Autoimmun; 2020 May; 109():102440. PubMed ID: 32201226 [TBL] [Abstract][Full Text] [Related]
17. Inositol-Requiring Enzyme 1α-Mediated Synthesis of Monounsaturated Fatty Acids as a Driver of B Cell Differentiation and Lupus-like Autoimmune Disease. Zhang Y; Gui M; Wang Y; Mani N; Chaudhuri S; Gao B; Li H; Kanwar YS; Lewis SA; Dumas SN; Ntambi JM; Zhang K; Fang D Arthritis Rheumatol; 2021 Dec; 73(12):2314-2326. PubMed ID: 34105254 [TBL] [Abstract][Full Text] [Related]
18. Inducible deletion of Ezh2 in CD4+ T cells inhibits kidney T cell infiltration and prevents interstitial nephritis in MRL/lpr lupus-prone mice. Zheng X; Dozmorov MG; Espinoza L; Bowes MM; Bastacky S; Sawalha AH bioRxiv; 2024 May; ():. PubMed ID: 38496595 [TBL] [Abstract][Full Text] [Related]
19. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice. Rankin AL; Guay H; Herber D; Bertino SA; Duzanski TA; Carrier Y; Keegan S; Senices M; Stedman N; Ryan M; Bloom L; Medley Q; Collins M; Nickerson-Nutter C; Craft J; Young D; Dunussi-Joannopoulos K J Immunol; 2012 Feb; 188(4):1656-67. PubMed ID: 22231702 [TBL] [Abstract][Full Text] [Related]
20. Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination. Zan H; Zhang J; Ardeshna S; Xu Z; Park SR; Casali P Autoimmunity; 2009 Feb; 42(2):89-103. PubMed ID: 19156553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]